james murphy cv - uc san diego school of medicine · 2016 red journal outstanding reviewer award...

JAMES D MURPHY, MD MS University of California San Diego email: [email protected]

Department of Radiation Medicine and Applied Sciences phone: 858-534-3508

Altman Clinical Translational Research Institute

9452 Medical Center Dr, La Jolla, CA 92037

La Jolla, CA 92037

EDUCATION

1996-2000 COLUMBIA UNIVERSITY, New York, New York

BS in Applied Mathematics

Graduated Honors with Distinction and Departmental Honors

Elected to Tau Beta Pi Engineering Honor Society

2002-2007 UNIVERSITY OF MICHIGAN MEDICAL SCHOOL, Ann Arbor, Michigan

MD conferred May, 2007

2007-2008 SAINT JOSEPH MERCY HOSPITAL, Ann Arbor, Michigan

Preliminary Medicine Intern

2008-2012 STANFORD UNIVERSITY, Department of Radiation Oncology, Palo Alto, California

Resident in Radiation Oncology

2009-2010 STANFORD UNIVERSITY, Health Research and Policy, Palo Alto, California

MS in Epidemiology

EMPLOYMENT

2012-2016 Assistant Professor, Department of Radiation Medicine and Applied Sciences,

University of California, San Diego

2016-present Associate Professor, Department of Radiation Medicine and Applied Sciences,


Service Chief of Gastrointestinal Radiation Oncology

Service Chief of Palliative Radiation Oncology

2016-present Clinical Investigator

Kaiser Permanente Center for Health Research, Portland, OR

2017-present Academic Community Director, School of Medicine


AWARDS/HONORS

2000 USRowing Scholar-Athlete (one of ten awarded in the US)

2000 Columbia University Academic-Athlete Award (I was the only recipient of this award;

this award is not given every year)

2002-2007 University of Michigan - Allen Lichter Dean’s Merit Scholarship (full-tuition, four-year

merit scholarship, awarded to top 5% of entering class; $155,000)

2006 Newman Professorship ASTRO Travel Award ($2,000)

James D Murphy

2

2006 University of Michigan Department of Radiation Oncology Senior Scholarship ($25,000)

2007-2008 St Joseph Mercy Hospital - Internal Medicine Intern of the Year

2009-2010 Stanford Department of Epidemiology Scholarship ($14,000)

2009-2010 Henry S Kaplan Resident Education Scholarship ($23,000)

2010 ASCO/AACR Workshop on Methods in Clinical Cancer Research

2011 American Radium Society Annual Meeting Travel Grant ($1,000)

2011 NCCN Fellows Recognition Program

2011 Richard T Hoppe Leadership Award

2013 UCSD Rad Onc of the Year

2014 UCSD Rad Onc of the Year

2014-2015 Association of Residents in Radiation Oncology (ARRO) Educator of the Year

2016 Whitehill Prize for Excellence in Teaching

2016 Red Journal Outstanding Reviewer Award

SERVICE

2013- NCCN Colon/Rectal/Anal Guidelines Panel Member

2013- RSNA Medical Student Grant Review Panel Member

2013- UCSD Moores Cancer Center Protocol Review and Monitoring System Committee

2013- UCSD Radiation Oncology Director of Medical Student Education

2013- UCSD Medical School Admissions Committee Member

2014- UCSD Radiation Oncology Clinical Competency Committee Chair

2014- UCSD Clinical Translational Research Institute (CTRI) Grant Reviewer

2015- SWOG Gastrointestinal Cancer Committee

2015- SWOG Gastrointestinal Cancer Working Group

2015- UCSD Radiation Oncology Associate Residency Program Director

2015- International Journal of Radiation, Biology, Physics Associate Editor

2016- ASTRO Gastrointestinal abstract reviewer

2016- UCSD Masters in Clinical Research (CLRE) Core Faculty Member

2016- ASTRO Comparative Effectiveness Research Resource Panel

2017- ASTRO Education Committee

2017- UCSD CREST program Admissions Committee

2017- UCSD CREST program Curriculum and Faculty Development Committee

2017- UCSD CREST program Mentorship Committee

MANUSCRIPTS

1. Murphy JD, Adusumilli S, Griffith KA, Ray ME, Zalupski MM, Lawrence TS, Ben-Josef E. Full-

dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer. Int J Radiat Oncol

Biol Phys. 2007 Jul 1;68(3):801-8. PubMed PMID: 17379445.

2. Feng M*, Murphy J* (co-first authorship), Griffith KA, Baker LH, Sondak VK, Lucas DR, McGinn

CJ, Ray ME. Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcoma. Int

J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):103-10. PubMed PMID: 17560050.

3. Murphy JD, Lucas DR, Somnay YR, Hamstra DA, Ray ME. Gemcitabine-mediated

radiosensitization of human soft tissue sarcoma. Transl Oncol. 2008 Mar;1(1):50-6. PubMed PMID:

18607508.

James D Murphy

3

4. Murphy JD, Spalding AC, Somnay YR, Markwart S, Ray ME, Hamstra DA. Inhibition of mTOR

radiosensitizes soft tissue sarcoma and tumor vasculature. Clin Cancer Res. 2009 Jan 15;15(2):589-

96. PubMed PMID: 19147764.

5. Murphy JD, Christman-Skieller C, Kim J, Dieterich S, Chang DT, Koong AC. A dosimetric model

of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer. Int J Radiat Oncol

Biol Phys. 2010 Dec 1;78(5):1420-6. PubMed PMID: 20399033.

6. Daly ME, Murphy JD, Mok E, Christman-Skieller C, Koong AC, Chang DT. Rectal and bladder

deformation and displacement during preoperative radiotherapy for rectal cancer: Are current margin

guidelines adequate for conformal therapy? Pract Radiat Oncol. 2011 Apr-Jun;1(2):85-94. PubMed

PMID: 24673921.

7. Kozak MM, Murphy JD, Schipper ML, Donington JS, Zhou L, Whyte RI, Shrager JB, Hoang CD,

Bazan J, Maxim PG, Graves EE, Diehn M, Hara WY, Quon A, Le QT, Wakelee HA, Loo BW Jr.

Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally

advanced non-small cell lung cancer. J Thorac Oncol. 2011 May;6(5):920-6. PubMed PMID:

21774104.

8. Johnston E, Diehn M, Murphy JD, Loo BW Jr, Maxim PG. Reducing 4D CT artifacts using

optimized sorting based on anatomic similarity. Med Phys. 2011 May;38(5):2424-9. PubMed PMID:

21776777.

9. Murphy JD, La TH, Chu K, Quon A, Fischbein NJ, Maxim PG, Graves EE, Loo BW Jr, Le QT.

Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer. Int J Radiat Oncol

Biol Phys. 2011 Jun 1;80(2):514-21. PubMed PMID: 20646870.

10. Daly ME, Le QT, Kozak MM, Maxim PG, Murphy JD, Hsu A, Loo BW Jr, Kaplan MJ, Fischbein

NJ, Chang DT. Intensity-modulated radiotherapy for oral cavity squamous cell carcinoma: patterns of

failure and predictors of local control. Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1412-22.

PubMed PMID: 20675073.

11. Das M, Donington JS, Murphy J, Kozak M, Eclov N, Whyte RI, Hoang CD, Zhou L, Le QT, Loo

BW, Wakelee H. Results from a single institution phase II trial of concurrent

docetaxel/carboplatin/radiotherapy followed by surgical resection and consolidation

docetaxel/carboplatin in stage III non-small-cell lung cancer. Clin Lung Cancer. 2011 Sep;12(5):280-

5. PubMed PMID: 21752720.

12. Meng X, Loo BW Jr, Ma L, Murphy JD, Sun X, Yu J. Molecular imaging with 11C-PD153035

PET/CT predicts survival in non-small cell lung cancer treated with EGFR-TKI: a pilot study. J Nucl

Med. 2011 Oct;52(10):1573-9. PubMed PMID: 21903741.

13. Maxim PG, Loo BW Jr, Murphy JD, Chu KP, Hsu A, Le QT. On-board imaging validation of

optically guided stereotactic radiosurgery positioning system for conventionally fractionated

radiotherapy for paranasal sinus and skull base cancer. Int J Radiat Oncol Biol Phys. 2011 Nov

15;81(4):1153-9. PubMed PMID: 21543166.

14. Murphy JD, Chisholm KM, Daly ME, Wiegner EA, Truong D, Iagaru A, Maxim PG, Loo BW Jr,

Graves EE, Kaplan MJ, Kong C, Le QT. Correlation between metabolic tumor volume and pathologic

tumor volume in squamous cell carcinoma of the oral cavity. Radiother Oncol. 2011 Dec;101(3):356-

61. PubMed PMID: 21665308.

James D Murphy

4

15. Abelson JA, Murphy JD, Wiegner EA, Abelson D, Sandman DN, Boas FE, Hristov D, Fleischmann

D, Daly ME, Chang DT, Loo BW Jr, Hara W, Le QT. Evaluation of a metal artifact reduction

technique in tonsillar cancer delineation. Pract Radiat Oncol. 2012 Jan-Mar;2(1):27-34. PubMed

PMID: 24674033.

16. Murphy JD, Chang DT, Abelson J, Daly ME, Yeung HN, Nelson LM, Koong AC. Cost-

effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer. Cancer. 2012

Feb 15;118(4):1119-29. PubMed PMID: 21773972.

17. Abelson JA, Murphy JD, Minn AY, Chung M, Fisher GA, Ford JM, Kunz P, Norton JA, Visser BC,

Poultsides GA, Koong AC, Chang DT. Intensity-modulated radiotherapy for pancreatic

adenocarcinoma. Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):e595-601. PubMed PMID:

22197234.

18. Wiegner EA, Daly ME, Murphy JD, Abelson J, Chapman CH, Chung M, Yu Y, Colevas AD,

Kaplan MJ, Fischbein N, Le QT, Chang DT. Intensity-modulated radiotherapy for tumors of the nasal

cavity and paranasal sinuses: clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys.

2012 May 1;83(1):243-51. PubMed PMID: 22019239.

19. Hunter KU, Feng FY, Griffith KA, Francis IR, Lawrence TS, Desai S, Murphy JD, Zalupski MM,

Ben-Josef E. Radiation therapy with full-dose gemcitabine and oxaliplatin for unresectable pancreatic

cancer. Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):921-6. PubMed PMID: 22208966.

20. Chu KP*, Murphy JD* (co-first authorship), La TH, Krakow TE, Iagaru A, Graves EE, Hsu A,

Maxim PG, Loo B, Chang DT, Le QT. Prognostic value of metabolic tumor volume and velocity in

predicting head-and-neck cancer outcomes. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1521-7.


21. Tang C*, Murphy JD* (co-first authorship), Khong B, La TH, Kong C, Fischbein NJ, Colevas AD,

Iagaru AH, Graves EE, Loo BW Jr, Le QT. Validation that metabolic tumor volume predicts outcome

in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1514-20. PubMed PMID:

22270174.

22. Abelson JA, Murphy JD, Loo BW Jr, Chang DT, Daly ME, Wiegner EA, Hancock S, Chang SD, Le

QT, Soltys SG, Gibbs IC.Esophageal tolerance to high-dose stereotactic ablative radiotherapy. Dis

Esophagus. 2012 Sep-Oct;25(7):623-9. PubMed PMID: 22168251.

23. Abelson JA, Murphy JD, Trakul N, Bazan JG, Maxim PG, Graves EE, Quon A, Le QT, Diehn M,

Loo BW Jr. Metabolic imaging metrics correlate with survival in early stage lung cancer treated with

stereotactic ablative radiotherapy. Lung Cancer. 2012 Dec;78(3):219-24. PubMed PMID: 23009727.

24. Jiang W, Murphy J, Van de Rijn M, Donaldson SS. Secondary breast angiosarcoma and germ line

BRCA mutations: discussion of genetic susceptibility. Journal of radiation oncology. 2013; 2(3):331-

335.

25. Paravati AJ, Healy E, Murphy JD, Song W, Hattangadi-Gluth J. Stereotactic body radiation therapy

for primary hepatic malignancies and liver metastases. Translational Cancer Research. 2013;

2(6):507-520.

James D Murphy

5

26. Taniguchi CM, Murphy JD, Eclov N, Atwood TF, Kielar KN, Christman-Skieller C, Mok E, Xing

L, Koong AC, Chang DT.Dosimetric analysis of organs at risk during expiratory gating in stereotactic

body radiation therapy for pancreatic cancer. Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1090-

5. PubMed PMID: 23273994.

27. Tang C, Fischbein NJ, Murphy JD, Chu KP, Bavan B, Dieterich S, Hara W, Kaplan MJ, Colevas

AD, Le QT. Stereotactic radiosurgery for retreatment of gross perineural invasion in recurrent

cutaneous squamous cell carcinoma of the head and neck. Am J Clin Oncol. 2013 Jun;36(3):293-8.


28. Murphy JD, Nelson LM, Chang DT, Mell LK, Le QT. Patterns of care in palliative radiotherapy: a

population-based study. J Oncol Pract. 2013 Sep;9(5):e220-7. PubMed PMID: 23943892.

29. Liu MB, Eclov NC, Trakul N, Murphy J, Diehn M, Le QT, Dieterich S, Maxim PG, Loo BW Jr.

Clinical impact of dose overestimation by effective path length calculation in stereotactic ablative

radiation therapy of lung tumors. Pract Radiat Oncol. 2013 Oct-Dec;3(4):294-300. Epub 2012 Oct

24. PubMed PMID: 24674401.

30. Zeidan YH, Shultz DB, Murphy JD, An Y, Chan C, Kaplan MJ, Colevas AD, Kong C, Chang DT,

Le QT. Long-term outcomes of surgery followed by radiation therapy for minor salivary gland

carcinomas. Laryngoscope. 2013 Nov;123(11):2675-80. PubMed PMID: 23553253.

31. Hong JC, Murphy JD, Wang SJ, Koong AC, Chang DT. Chemoradiotherapy before and after

surgery for locally advanced esophageal cancer: a SEER-Medicare analysis. Ann Surg Oncol. 2013

Nov;20(12):3999-4007. PubMed PMID: 23800897.

32. Hiniker SM, Roux A, Murphy JD, Harris JP, Tran PT, Kapp DS, Kidd EA. Primary squamous cell

carcinoma of the vagina: prognostic factors, treatment patterns, and outcomes. Gynecol Oncol. 2013

Nov;131(2):380-5. PubMed PMID: 23954572.

33. Tang C, Komakula S, Chan C, Murphy JD, Jiang W, Kong C, Lee-Enriquez N, Jensen KC,

Fischbein NJ, Le QT. Radiologic assessment of retropharyngeal node involvement in oropharyngeal

carcinomas stratified by HPV status. Radiother Oncol. 2013 Nov;109(2):293-6. PubMed PMID:

24103114.

34. Simpson DR, Martínez ME, Gupta S, Hattangadi-Gluth J, Mell LK, Heestand G, Fanta P,

Ramamoorthy S, Le QT, Murphy JD. Racial disparity in consultation, treatment, and the impact on

survival in metastatic colorectal cancer. J Natl Cancer Inst. 2013 Dec 4;105(23):1814-20. PubMed

PMID: 24231453.

35. Murphy JD, Hattangadi-Gluth J, Song WY, Vollans E, Camborde ML, Kosztyla R, Loewen SK,

Crumley C, Moiseenko V. Liver toxicity prediction with stereotactic body radiation therapy: The

impact of accounting for fraction size. Pract Radiat Oncol. 2014;4(6):372-7. PubMed PMID:

25407857.

36. Shultz DB, Zeidan YH, Murphy JD, Hara W, Kaplan MJ, et al. Radiotherapy for adenoid cystic

carcinomas of the head and neck: clinical outcomes and patterns of failure. Journal of radiation

oncology. 2014; 3(1):49-56.

James D Murphy

6

37. Pham NL, Reddy PV, Murphy JD, Sanghvi P, Hattangadi-Gluth JA, et al. Frameless, real-time,

surface imaging-guided radiosurgery: update on clinical outcomes for brain metastases. Translational

cancer research. 2014; 3(4):351-357.

38. White EC, Murphy JD, Chang DT, Koong AC. Low Toxicity in Inflammatory Bowel Disease

Patients Treated With Abdominal and Pelvic Radiation Therapy. Am J Clin Oncol. 2014 Jan 7.


39. Sonier M, Gete E, Herbert C, McKenzie M, Murphy J, Moiseenko V. Intensity-modulated

stereotactic radiosurgery for arteriovenous malformations: guidance for treatment planning. Radiat

Oncol. 2014 Mar 10;9:73. PubMed PMID: 24612667.

40. Harris JP, Murphy JD, Hanlon AL, Le QT, Loo BW Jr, Diehn M. A population-based comparative

effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer. Int J

Radiat Oncol Biol Phys. 2014 Mar 15;88(4):872-84. PubMed PMID: 24495591.

41. Shultz DB, Trakul N, Abelson JA, Murphy JD, Maxim PG, Le QT, Loo BW Jr, Diehn M. Imaging

features associated with disease progression after stereotactic ablative radiotherapy for stage I non-

small-cell lung cancer. Clin Lung Cancer. 2014 Jul;15(4):294-301. PubMed PMID: 24594400.

42. Benson AB 3rd, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger

PC, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, Messersmith W, Mulcahy

MF, Murphy JD, Nurkin S, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM,

Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Gregory KM, Freedman-Cass DA;

National Comprehensive Cancer Network. Colon cancer, version 3.2014. J Natl Compr Canc Netw.

2014 Jul;12(7):1028-59. PubMed PMID: 24994923.

43. Carmona R, Gulaya S, Murphy JD, Rose BS, Wu J, Noticewala S, McHale MT, Yashar CM, Vaida

F, Mell LK. Validated competing event model for the stage I-II endometrial cancer population. Int J

Radiat Oncol Biol Phys. 2014 Jul 15;89(4):888-98. PubMed PMID: 24969798.

44. Paravati AJ, Murphy JD. Cost-effectiveness in radiation oncology: an uncomfortable but necessary

question. Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):784-5. PubMed PMID: 24969792.

45. Wong J, Xu B, Yeung HN, Roeland EJ, Martinez ME, Le QT, Mell LK, Murphy JD. Age disparity

in palliative radiation therapy among patients with advanced cancer. Int J Radiat Oncol Biol Phys.

2014 Sep 1;90(1):224-30. PubMed PMID: 25195994.

46. Yeung HN, Mitchell WM, Roeland EJ, Xu B, Mell LK, Le QT, Murphy JD. Palliative radiation

before hospice: the long and the short of it. J Pain Symptom Manage. 2014 Dec;48(6):1070-9.


47. Ma GL*, Murphy JD* (co-first authorship), Martinez ME, Sicklick JK. Epidemiology of

gastrointestinal stromal tumors in the era of histology codes: results of a population-based study.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):298-302. PubMed PMID: 25277795.

48. Tang C, Chan C, Jiang W, Murphy JD, von Eyben R, Colevas AD, Pinto H, Lee-Enriquez N, Kong

C, Le QT. Concurrent cetuximab versus platinum-based chemoradiation for the definitive treatment

of locoregionally advanced head and neck cancer. Head Neck. 2015 Mar;37(3):386-92. PubMed

PMID: 24431011.

James D Murphy

7

49. Xu B, Boero IJ, Hwang L, Le QT, Moiseenko V, Sanghvi PR, Cohen EE, Mell LK, Murphy JD.

Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer. Cancer. 2015

Apr 15;121(8):1303-11. PubMed PMID: 25537836.

50. Murphy JD*, Ma GL* (co-first authorship), Baumgartner JM, Madlensky L, Burgoyne AM, Tang

CM, Martinez ME, Sicklick JK. Increased risk of additional cancers among patients with

gastrointestinal stromal tumors: A population-based study. Cancer. 2015 Apr 30. PubMed PMID:

25930983.

51. Rahn DA 3rd, Mundt AJ, Murphy JD, Schiff D, Adams J, Murphy KT. Clinical outcomes of

palliative radiation therapy for children. Pract Radiat Oncol. 2015 May-Jun;5(3):183-7. PubMed

PMID: 25413394.

52. Li Y, Hoisak JD, Li N, Jiang C, Tian Z, Gautier Q, Zarepisheh M, Wu Z, Liu Y, Jia X, Hattangadi-

Gluth J, Mell LK, Jiang S, Murphy JD. Dosimetric benefit of adaptive re-planning in pancreatic

cancer stereotactic body radiotherapy. Med Dosim. 2015 May 19. pii: S0958-3947(15)00035-7.


53. Heestand GM, Murphy JD, Lowy AM. Approach to Patients With Pancreatic Cancer Without

Detectable Metastases. J Clin Oncol. 2015 Jun 1;33(16):1770-1778. PubMed PMID: 25918279.

54. Paravati A, Boero IJ, Triplett DP, Hwang L, Matsuno RK, Xu B, Mell LK, Murphy JD. Variation in

the cost of radiation therapy among Medicare patients with cancer. J Oncol Pract. 2015; 11(5):403-9.


55. Benson AB, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger PC,

Fenton MJ, Fuchs CS, Grem JL, Grothey A, Hochster HS, Hunt S, Kamel A, Kirilcuk N, Leong LA,

Lin E, Messersmith WA, Mulcahy MF, Murphy JD, Nurkin S, Rohren E, Ryan DP, Saltz L, Sharma

S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Gregory

KM1 Freedman-Cass D. Rectal Cancer, Version 2.2015. J Natl Compr Canc Netw. 2015

Jun;13(6):719-28. PMID: 26085388.

56. Boero IJ, Paravati A, Triplett DP, Hwang L, Matsuno RK, Mell LK, Murphy JD. The impact of

radiotherapy costs on clinical outcomes in breast cancer. Radiother Oncol. 2015; 117(2):393-9.

PubMed PMID 26472317.

57. Boero IJ, Paravati A, Xu B, Cohen EE, Mell LK, Le QT, Murphy JD. The importance of radiation

oncologist experience among head-and-neck cancer patients treated with intensity modulated

radiation therapy. J Clin Oncol. 2016, 34(7):684-90. PMID: 26729432.

58. Boero IJ, Triplett DP, Paravati A, Hwang L, Matsuno R, Gillespie EF, Yashar CM, Moiseenko V,

Einck JP, Mell LK, Parikh SA, Murphy JD. Modern radiation therapy and cardiac outcomes in

breast cancer. Int J Radiat Oncol Biol Phys. 2016; 94(4):700-8. PMID: 26972642.

59. Gomez SL, Hurley S, Canchola AJ, Keegan T, Cheng I, Murphy JD, Clarke C, Glaser SL, Martinez

ME. Effects of economic resources and marital status on survival after cancer: a population-based

study. Cancer. 2016, 122(10):1618-25. PMID: 27065317.

James D Murphy

8

60. Martinez M, Anderson K, Murphy J, Hurley S, Canchola A, Keegan T, Cheng I, Clarke C, Glaser S,

Gomez. Differences in marital status and mortality by race/ethnicity and nativity among California

cancer patients. Cancer. 2016, 122(10):1570-8. PMID: 27065455.

61. Carmona R, Zakeri K, Green G, Hwang L, Gulaya S, Xu B, Verma R, Williamson CW, Triplett DP,

Rose BS, Shen H, Vaida F, Murphy JD, Mell LK. Improved method to stratify elderly cancer

patients at risk for competing events. J Clin Oncol. 2016, 34(11):1270-7. PMID: 26884579.

62. Roeland EJ, Triplett DP, Matsuno RK, Boero IJ, Hwang L, Revta C, Yeung HN, Murphy JD.

Patterns of palliative care consultation among elderly cancer patients. J Natl Compr Canc Netw. 2016,

14(4):439-45. PMID: 27059192. 63. Coe TM, Fero KE, Murphy JD, Fanta PT, Mallory RJ, Tang C, Sicklick JK. Population-based

epidemiology of small malignant gastrointestinal stromal tumors in the United States. J Gastrointest

Surg. 2016, 20(6):1132-40. PMID: 27025710 64. Apisarnthanarax S, Cheng JCH, Jabbour SK, Liauw SL, Murphy JD, Chang DT. Gastrointestinal

cancers-changing the standard for rectal cancer and establishing a new standard for liver tumors. Int J

Radiat Oncol Biol Phys. 2016, 95(3):930-6. PMID: 27302509.

65. Gillespie EF, Matsuno RK, Xu B, Triplett DP, Hwang L, Boero IJ, Einck JP, Yashar C, Murphy JD.

Geographic disparity in the use of hypofractionated radiotherapy among elderly women undergoing

breast conservation for invasive breast cancer. Int J Radiat Oncol Biol Phys. 2016, 96(2):251-8.

PMID: 27473817.

66. Acevedo JR, Fero KE, Wilson B, Sacco AG, Mell LK, Coffey CS, Murphy JD. Cost-effectiveness

analysis of elective neck dissection in patients with clinically node-negative oral cavity cancer. J Clin

Oncol. 2016, 34(32):3886-91. PMID: 27551113.

67. Gillespie EF, Panjwani N, Mundt AJ, Murphy JD. eContour: a novel web-based interactive

contouring atlas to improve quality of care at the point-of-care. Contemporary Radiation Oncology,

June 2016.

68. Moiseenko V, Murphy JD, Einck JP, Murphy JD, Oden J, Bjohle J, Uzan J, Gagliardi G. Clinical

evaluation of QUANTEC guidelines to predict the risk of cardiac mortality in breast cancer patients.

Acta Oncol. 2016, 55(12):1506-1510. PMID: 27732122.

69. Fero KE, Coe TM, Fanta PT, Tang CM, Murphy JD, Sicklick JK. Surgical management of

adolescents and young adults with gastrointestinal stromal tumors: A population-based analysis in the

United States. JAMA Surg. 2017, 152(5):443-451. PMID: 28114506.

70. McClelland S 3rd, Kim E, Murphy JD, Jaboin JJ. Nonoperative management of acoustic neuroma in

geriatric patients: A National Cancer Database analysis. J Radiat Oncol. 2016, 5: 345.

71. Boero IJ, Gillespie EF, Hou J, Paravati AJ, Kim E, Einck JP, Yashar C, Mell LK, Murphy JD. The

impact of radiation oncologist on the early adoption of hypofractionated radiotherapy for early-stage

breast cancer. Int J Radiat Oncol Biol Phys. 2017, 97(3):571-580. PMID: 28126306.

James D Murphy

9

72. Shi E, Wang K, Tang CM, Murphy JD, Fanta PT, Ali SM, Madlensky L, Heestand GM, Kurzrock R,

Morosini D, Ross JS, Harismendy O, Sicklick JK. FGFR1 and NTRK3 actionable alterations in

"wild-type" gastrointestinal stromal tumors. J Transl Med. 2016, 14(1):339. PMID: 27974047.

73. Kaderka R, Paravati A, Sarkar R, Tran J, Fero K, Panjwani N, Simpson D, Murphy J, AtwoodT.

Correlation of liver and pancreas tumor motion with normal anatomical structures determined with

deformable image registration. Biomed Phys Eng Express. 2017, 3(1).

74. Martin EJ, Roeland EJ, Sharp MB, Revta C, Murphy JD, Fero KE, Yeung HN. Patient-controlled

analgesia for cancer-related pain: clinical predictors of patient outcomes. J Natl Compr Canc Netw.

2017, 15(5):595-600. PMID 28476739.

75. Chen V, Lu S, Zakeri K, Murphy JD, Yashar C, Einck JP. Pathologic response after neoadjuvant

chemotherapy predicts locoregional control in patients with triple negative breast cancer. Advances in

Radiation Oncology. 2017, 2(2):105-109.

76. Gillespie EF, Panjwani N, Golden DW, Gunther J, Chapman TR, Brower JV, Kosztyla R, Larson G,

Neppala P, Moiseenko V, Bykowski J, Sanghvi P, Murphy JD. Multi-institutional randomized trial

testing the utility of an interactive three-dimensional contouring atlas among radiation oncology

residents. Int J Radiat Oncol Biol Phys. 2017, 98(3):547-554. PMID: 28262474.

77. Bryant AK, Banegas MP, Martinez ME, Mell LK, Murphy JD. Trends in radiation therapy among

cancer survivors in the United States, 2000-2030. Cancer Epidemiol Biomarkers Prev. 2017,

26(6):963-970.

78. McClelland S 3rd, Kim E, Murphy JD, Jaboin JJ. Impact of Insurance Status and Race on Receipt of

Treatment for Acoustic Neuroma: A National Cancer Database Analysis. Journal of Clinical

Neuroscience. 2017, in press. PMID 28343920.

79. McClelland S 3rd, Kim E, Murphy JD, Jaboin JJ. Operative Mortality Rates of Acoustic Neuroma

Surgery: A National Cancer Database Analysis. Otol Neurotol. 2017, 38(5):751-753. PMID:

28187056

80. Wali AR, Park CC, Santiago Dieppa DR, Vaida F, Murphy JD, Khalessi AA. Pipeline embolization

device versus coiling for the treatment of large and giant unruptured intracranial aneurysms: a cost-

effectiveness analysis. Neurosurg Focus. 2017 Jun;42(6):E6. PMID: 28565986.

81. Benson AB 3rd, Venook AP, Cederquist L, Chan E, Chen YJ, Cooper HS, Deming D, Engstrom PF,

Enzinger PC, Fichera A, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N,

Krishnamurthi S, Messersmith WA, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata

D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wu CS, Gregory KM,

Freedman-Cass D. Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J

Natl Compr Canc Netw. 2017 Mar;15(3):370-398. PMID: 28275037.

82. Tringale K, Marshall D, Mackey T, Connor M, Murphy J, Hattangadi-Gluth J. Types and

distribution of payments from industry to physicians in 2015. JAMA. 2017; 317(17):1774-1784.

PMID: 28464140.

James D Murphy

10

83. Ward EP, Unkart JT, Bryant A, Murphy J, Blair S. Influence of distance to hospital and insurance

status on the rates of contralateral prophylactic mastectomy, a NCDB study. Ann Surg Oncol. 2017, in

press.

84. Triplett DP, LeBrett WG, Bryant AK, Bruggeman AR, Matsuno RK, Hwang L, Boero IJ, Roeland EJ,

Yeung HN, Murphy JD. Impact of palliative care on aggressiveness of end-of-life care among

patients with advanced cancer. J Oncol Pract. 2017, in press.

85. Apisarnthanarax S, Jabbour SK, Liauw SL, Murphy JD, Olsen J, Chang DT. Gastrointestinal

Cancers: Timing Is Everything. Int J Radiat Oncol Biol Phys. 2017, in press.

86. Bryant AK, Huynh-Le MP, Simpson DR, Gupta S, Sharabi AB, Murphy JD. Outcomes of anal

squamous cell carcinoma among HIV positive patients in the modern era. JAMA Oncol. 2017, in

press.

87. Cerviño L, Soultan D, Cornell M, Yock A, Pettersson N, Song WY, Aguilera J, Murphy J, Ho C,

James C, Paravati A, Coope R, Gill B, Moiseenko V. A novel 3D printed phantom for 4D PET/CT

imaging and simultaneous-integrated boost radiotherapy. Med Phys. 2017, in press.

88. Bryant AK, Sandhu AP, Urbanic JJ, Sharabi AB, Gupta S, Daly ME, Murphy JD. Stereotactic body

radiation therapy versus surgery for early non-small-cell lung cancer in the Veterans Affairs system.

Ann Thorac Surg. 2017, in press.

89. Bryant AK, Mudgway R, Huynh-Le MP, Simpson DR, Mell LK, Gupta S, Sharabi AB, Murphy JD.

Effect of CD4 count on treatment toxicity and tumor recurrence in HIV positive patients with anal

cancer. Int J Radiat Oncol Biol Phys. 2017, in press.

90. Fero K, Hamilton ZA, Bindayi A, Murphy JD, Derweesh IH. Utilization and quality outcomes of

cT1a, cT1b and cT2a partial nephrectomy: analysis of the United States National Cancer Database.

BJU Int. 2017, in press.

91. Tringale KR, Carroll KT, Zakeri K, Sacco A, Barnachea L, Murphy JD. Cost-effectiveness analysis

of Nivolumab for treatment of platinum-resistant recurrent or metastatic squamous-cell carcinoma of

the head and neck. J Natl Cancer Inst. 2017, in press.

92. Atwood TF, Brown DW, Murphy JD, Moore KL, Mundt AJ, Pawlicki TP. Care for patients, not for

charts: a future for clinical medical physics. Int J Radiat Oncol Biol Phys. 2017, in press.

93. McClelland S 3rd, Kim E, Passias PG, Murphy JD, Attia A, Jaboin JJ. Spinal stereotactic body

radiotherapy in the United States: a decade-long nationwide analysis of patient demographics,

practice patterns, and trends over time. Journal of Clinical Neuroscience, 46:109-112, 2017. PMID:

28864408.

94. Earles A, Liu L, Bustamante R, Coke P, Lynch J, Messer K, Martinez EM, Murphy JD, Williams

CD, Provenzale D, Gawron AJ, Kaltenbach T, DuVall SL, Kelley MJ, Gupta S. A structured

approach to evaluate strategies for cancer ascertainment using large-scale electronic health record

data. JCO Clin Cancer Inform, 2017, in press.

James D Murphy

11

95. Pettersson N, Simpson D, Atwood T, Hattangadi-Gluth J, Murphy J, Cerviño L. Automatic patient

positioning and gating window settings in respiratory-gated stereotactic body radiation therapy for

pancreatic cancer using fluoroscopic imaging. J Appl Clin Med Phys. 2017, in press.

* indicates co-first authorship

ABSTRACTS

1. Murphy JD, Adusumilli S, Lawrence TS, Ben-Josef E. Full-dose gemcitabine and concurrent

radiotherapy for unresectable pancreatic cancer: Analysis of toxicity. Proceedings of the 48th Annual

ASTRO Meeting, November 2006;66(3):S265-S266.

2. Ray ME, Murphy JD, Feng M, Baker LH, Sondak VK, Lucas DR, Griffith KA, McGinn C.

Outcomes after combined modality treatment of retroperitoneal sarcomas. 12th Annual Connective

Tissue Oncology Society Meeting, November 2006.

3. Ray ME, Murphy JD. Gemcitabine-mediated radiosensitization of human soft tissue sarcoma. 12th

Annual Connective Tissue Oncology Society Meeting, November 2006.

4. Markwart S, Murphy JD, Ray ME. Gemcitabine-mediated radiosensitization of human soft tissue

sarcoma. Proceedings of the 48th Annual ASTRO Meeting, November 2006;66(3):S720-S721.

5. Ben-Josef E, Murphy JD, Normolle D, Adusumilli S, Ten Haken R, Ray ME, Vineberg K, Zalupski

M, Lawrence TS. Local control in patients with unresectable pancreatic cancer treated with radiation

and concurrent full-dose gemcitabine. Proceedings of the 48th Annual ASTRO Meeting, November

2006 66(3):S172.

6. Ray ME, Murphy JD, Feng M, Baker LH, Sondak VK, Lucas DR, Griffith KA, McGinn C.

Outcomes after combined modality treatment of retroperitoneal sarcomas. Proceedings of the 48th

Annual ASTRO Meeting, November 2006;66(3):S116-S117.

7. Feng FY, Griffith KA, Murphy JD, Francis IR, Desai SP, Lawrence TS, Zalupski MM, Ben-Josef E.

A Phase I trial of full-dose gemcitabine, oxaliplatin, and radiation therapy for unresectable pancreatic

cancer: Preliminary analysis. Proceedings of the 49th Annual ASTRO Meeting, November

2007;69(3):S308-S309.

8. Murphy JD, Gurchek K, Stojan JN, McNally PL. Extrapulmonary sarcoidosis – a clinical dilemma.

American College of Physicians Michigan Chapter Associates’ Scientific Meeting, May 2008;96.

9. Chu KPM, Murphy J, La TH, Loo BW, Krakow TE, Hsu A, Maxim PG, Graves E, Chang D, Le Q.

Prognostic value of metabolic tumor volume and velocity in predicting head and neck cancer

outcomes. Proceedings of the 52st Annual ASTRO Meeting, November 2010; 78(3):S460.

10. Taniguchi CM, Kielar KN, Murphy JD, Atwood TF, Christman-Skieller C, Dieterich S, Xing L,

Koong AC, Chang DT. Significant duodenal dose variation within the respiratory cycle during

stereotactic body radiotherapy for pancreatic cancer. Proceedings of the 52st Annual ASTRO Meeting,

November 2010; 78(3):S329.

11. Daly ME, Murphy JD, Mok E, Chang DT, Koong, AC. Rectal deformation and displacement during

pre-operative radiotherapy for rectal cancer: Insights from mid-treatment cone-beam computed

tomography. Proceedings of the 52st Annual ASTRO Meeting, November 2010; 78(3):S310.

James D Murphy

12

12. Abelson JA, Murphy J, Chang SD, Soltys SG, Le Q, Loo BW, Gibbs IC. Esophageal dose tolerance

in stereotactic body radiotherapy. Proceedings of the 52st Annual ASTRO Meeting, November 2010;

78(3):S267.

13. Murphy JD, Chang DT, Abelson J, Daly ME, Yeung HN, Nelson LM, Koong AC. Cost

effectiveness of radiotherapy in locally advanced pancreatic cancer. 2010, Proceedings of the 52st

Annual ASTRO Meeting, November 2010;78(3):S576.

14. Meng X, Yu J, Loo BW, Ma L, Sun X, Murphy JD, Zhao SQ, Kong L, Yang GR, Li WL, Zhao XG.

Molecular imaging with 11

c-PD153035 PET/CT predicts survival in non-small cell lung cancer treated

with EGFR-TKI. ASCO Annual Meeting, June 2011; J Clin Oncol 29 (suppl; abstr 10543).

15. Murphy JD, Abelson J, Chunb MP, Chang DT, Koong AC. Gastrointestinal normal tissue toxicity

prediction in stereotactic body radiotherapy. Proceedings of the 53rd

Annual ASTRO Meeting, October

2011.

16. Shultz DB, Murphy JD, Daly ME, Hara W, Le QT, Chang DT. Radiotherapy for adenoid cystic

carcinomas of the head and neck: clinical outcomes and patterns of failure. Proceedings of the 53rd

Annual ASTRO Meeting, October 2011.

17. Tang C, Murphy JD, Khong B, La TH, Iagaru AH, Graves EE, Kong C, Le QT. Validation that

metabolic tumor volume predicts outcome in head-and-neck cancer. Proceedings of the 53rd

Annual

ASTRO Meeting, October 2011.

18. Murphy JD, Nelson LM, Le QT. Increasing use of technology with palliative radiotherapy.

Proceedings of the 54th Annual ASTRO Meeting, October 2012.

19. Hiniker SM, Roux A, Murphy JD, Tran PT, Kapp DS, Kidd EA. Primary squamous cell carcinoma

of the vagina: prognostic factors, treatment patterns, and outcomes. Proceedings of the 54th Annual


20. Zeidan Y, Murphy JD, Chan C, An Y, Kaplan M, Colevas A, Kong C, Le Q. Postoperative radiation

therapy for minor salivary gland carcinomas of the head and neck: long-term outcomes. Proceedings

of the 54th Annual ASTRO Meeting, October 2012.

21. Shultz DB, Trakul N, Abelson JA, Murphy JD, Le QT, Loo BW, Diehn M. Anatomic and metabolic

predictors of failure after stereotactic ablative radiation therapy for non-small cell lung cancer.


22. Trakul N, Murphy JD, Loo BW, Diehn M. Improved outcomes in stage I NSCLC patients treated in

the stereotactic ablative radiation therapy era: a population-based analysis. Proceedings of the 54th


23. Murphy JD, Le QT. Racial inequality with radiation oncology referral and treatment in metastatic

colorectal cancer. ASCO 2013 Gastrointestinal Cancers Symposium, January 2013; J Clin Oncol 30:

2013.

24. Sutterley C, Gautier Q, Graves Y, Zarepisheh M, Li N, Tian Z, Jia X, Moore K, Rahn D, Murphy J,

Mell L, Jiang S. Evaluation of a GPU-based in-house automatic re-planning system for adaptive

James D Murphy

13

radiotherapy re-planning for head and neck cancer. American Association of Physicists in Medicine

Annual Meeting, August 2013.

25. Li Y, Hoisak J, Li N, Graves Y, Gautier Q, Tian Z, Zarepisheh M, Cervino L, Jia X, Jiang S, Murphy

J. A retrospective study on the potential clinical gain of on-line adaptive re-planning for pancreatic

cancer SBRT. American Association of Physicists in Medicine Annual Meeting, August 2013.

26. Einck J, Lu S, Murphy J, Yashar C. Residual disease in the breast or lymph nodes following

neoadjuvant chemotherapy for triple negative breast cancer results in a high risk of locoregional

failure despite the use of radiotherapy. Proceedings of the 55th Annual ASTRO Meeting, September

2013.

27. Simpson DR, Martinez ME, Gupta S, Hattangadi-Gluth J, Mell LK, Heestand G, Fanta P,

Ramamoorthy S, Le QT, Murphy JD. Racial Disparity in Consultation, Treatment, and the Impact

on Survival in Metastatic Colorectal Cancer. Proceedings of the 55th Annual ASTRO Meeting,

September 2013.

28. Gillespie E, Chen VE, Murphy J, Yashar CM, Lu SM, Einck JP. Pathologic Response After

Neoadjuvant Chemotherapy Predicts Locoregional Control in Patients With Triple-Negative Breast

Cancer. Proceedings of the 56th Annual ASTRO Meeting, September 2014.

29. Hattangadi JA, Murphy J, Sanghvi P, Racht A, Punglia RS. A 25-Year Epidemiologic Study of

Medical Malpractice Claims in Radiation Oncology. Proceedings of the 56th Annual ASTRO Meeting,

September 2014.

30. Xu B, Le Q, Sanghvi PR, Mell LK, Murphy JD. Aspiration Pneumonia After Chemoradiation

Therapy for Head and Neck Cancer. Proceedings of the 56th Annual ASTRO Meeting, September

2014.

31. Paravati AJ, Xu B, Mell LK, Murphy JD. Sources of Variation in the Cost of Radiation Therapy for

Breast, Lung, and Prostate Cancer. Proceedings of the 56th Annual ASTRO Meeting, September 2014.

32. Simpson DR, Ambite JL, Kosztyla R, Kumaraguruparan G, Liu M, Moore KL, Murphy JD, Wu J,

Moiseenko. A Novel Multi-Institutional Database for Tracking and Reporting Dose-Volume Data and

Normal Tissue Effects. Proceedings of the 56th Annual ASTRO Meeting, September 2014.

33. Soultan D, Murphy J, Gill B, Moiseenko V, Cervino L. A Novel 3D Printed Phantom for 4D

PET/CT Imaging and SIB Radiotherapy Verification. AAPM Annual Meeting, July 2015.

34. Soultan D, Murphy J, Hoh C, Gill B, Moiseenko V, Cervino L. Assessing Segmentation Accuracy of

Internal Volumes and Sub-Volumes in 4D PET/CT of Lung Tumors Using a Novel 3D Printed

Phantom. AAPM Annual Meeting, July 2015.

35. Boero IJ, Paravati AJ, Hwang L, Triplett DP, Matsuno RK, Xu B, Mell LK, Murphy JD. The Impact

of Cost on Clinical Outcomes After Radiation Therapy for Breast Cancer. Proceedings of the 57th


36. Boero IJ, Paravati AJ, Triplett DP, Hwang L, Matsuno RK, Gillespie EF, Yashar CM, Moiseenko V,

Einck JP, Mell LK, Parikh SA, Murphy JD. Modern Radiation Therapy and Cardiac Outcomes in

Breast Cancer. Proceedings of the 57th Annual ASTRO Meeting, October 2015.

James D Murphy

14

37. Boero IJ, Xu B, Mell LK, Le QT, Murphy JD. Impact of Radiation Oncologist Provider Volume on

Clinical Outcomes in Head and Neck Cancer. Proceedings of the 57th Annual ASTRO Meeting,

October 2015.

38. Carmona R, Green G, Eren AA, Eren MF, Murphy JD, Mell LK. Cost-Effectiveness of Gemcitabine

Plus Cisplatin and Intensity Modulated Radiation Therapy for Patients With Locally Advanced

Cervical Cancer. Proceedings of the 57th Annual ASTRO Meeting, October 2015.

39. Carmona R, Hwang L, Green G, Zakeri K, Murphy JD, Mell LK. Competing Event Models Improve

Risk Stratification of Elderly Breast Cancer Patients. Proceedings of the 57th Annual ASTRO

Meeting, October 2015.

40. Gillespie EF, Matsuno RK, Xu B, Triplett DP, Hwang L, Boero IJ, Murphy JD. Geographic

Disparity in the Use of Hypofractionated Radiation Therapy Among Elderly Women Undergoing

Breast Conservation for Invasive Breast Cancer. Proceedings of the 57th Annual ASTRO Meeting,

October 2015.

41. Green G, Carmona R, Jr., Hwang L, Murphy JD, Mell LK. Risk Factors for Esophageal Dilation in

the Elderly Head and Neck Cancer Population. Proceedings of the 57th Annual ASTRO Meeting,

October 2015.

42. Hwang L, Boero IJ, Triplett DP, Matsuno RK, Xu B, Gillespie EF, Einck JP, Murphy JD. Long-term

Gastrointestinal Toxicity After Surgery and Radiation in Prostate Cancer. Proceedings of the 57th


43. Hwang L, Boero IJ, Triplett DP, Matsuno RK, Xu B, Gillespie EF, Einck JP, Murphy JD.

Subsequent Cancer-Directed Therapy After Radical Prostatectomy: A Population-Based Analysis.


44. Hwang L, Boero IJ, Triplett DP, Matsuno RK, Xu B, Gillespie EF, Mell LK, Murphy JD. Outcomes

of Hypofractionated Versus Standard Fractionated Breast Cancer Radiation in the Real World: A

Population-Based Analysis. Proceedings of the 57th Annual ASTRO Meeting, October 2015.

45. Murphy JD, Oden J, Uzan J, Einck JP, Moiseenko V, Gagliardi G. QUANTEC Guidelines and

Predicted Cardiac Mortality Among Breast Cancer Patients. Proceedings of the 57th Annual ASTRO

Meeting, October 2015.

46. Pham NL, Reddy PV, Murphy JD, Sanghvi P, Hattangadi JA, Kim GY, Cervino LI, Pawlicki T,

Murphy KT. Frameless, Real Time, Surface Imaging Guided Radiosurgery: Clinical Outcomes for

Brain Metastases. Proceedings of the 57th Annual ASTRO Meeting, October 2015.

47. Seible DM, Murphy JD. The Impact of Local Disease Progression in Pancreatic Cancer at the End of

Life. Proceedings of the 57th Annual ASTRO Meeting, October 2015.

48. Zakeri K, Carmona R, Green G, Murphy JD, Mell LK. Competing Event Models Reduce Clinical

Trial Costs in Elderly Cancer Patients. Proceedings of the 57th Annual ASTRO Meeting, October

2015.

49. Zakeri K, Hwang L, Murphy JD. Long-term Risks of Radiation Therapy for Stage II/III Rectal

Cancer. Proceedings of the 57th Annual ASTRO Meeting, October 2015.

James D Murphy

15

50. Bruggeman A, Fero KE, Davis SW, Panjwani N, Murphy JD. Impact of radiation on pain in

Veterans Affairs patients with pancreatic cancer. Proceedings of the 57th Annual ASTRO Meeting,

September 2016.

51. Fero KE, Paravati AJ, Panjwani N, Boero IJ, Hwang L, Matsuno RK, Murphy JD. The impact of

radiation cost on patient outcomes after definitive radiation therapy in prostate cancer. Proceedings of

the 57th Annual ASTRO Meeting, September 2016.

52. Gillespie EF, Boero IJ, Paravati AJ, Hou J, Murphy JD. The impact of radiation oncology provider

on the likelihood of receiving hypofractionated whole-breast radiation therapy for early-stage breast

cancer. Proceedings of the 57th Annual ASTRO Meeting, September 2016.

53. Gillespie EF, Panjwani N, Golden DW, Gunther JR, Chapman TR, Brower JV, Kosztyla R,

Bykowski JM, Sanghvi P, Murphy JD. Educational impact of a novel web-based interactive

contouring atlas among radiation oncology residents in a multi-institutional randomized trial.

Proceedings of the 57th Annual ASTRO Meeting, September 2016.

54. Kim E, Murphy JD. Impact of radiation dose in neoadjuvant chemoradiation prior to surgery in

esophageal cancer. Proceedings of the 57th Annual ASTRO Meeting, September 2016.

55. Kim E, Murphy JD. Preoperative short-course radiation for localized rectal cancer in the United

States. Proceedings of the 57th Annual ASTRO Meeting, September 2016.

56. Kim E, Murphy JD. Squamous cell carcinoma of the rectum. Proceedings of the 57th Annual

ASTRO Meeting, September 2016.

57. Noticewala SS, Williamson CW, Murphy JD. Cost-effectiveness of proton therapy for

parameningeal rhabdomyosarcoma. Proceedings of the 57th Annual ASTRO Meeting, September

2016.

58. Panjwani N, Fero KE, Murphy JD. Cardiac toxicity with radiation therapy in esophageal cancer.


59. Panjwani N, Gillespie EF, Golden DW, Gunther JR, Chapman TR, Brower JV, Bykowski JM,

Sanghvi P, Murphy JD. Usability of a novel interactive web-based contouring atlas. Proceedings of

the 57th Annual ASTRO Meeting, September 2016.

60. Pham NL, Lytle N, Hattangadi JA, Murphy JD, Mundt AJ, III, Lowy AM, Reya T. Targeting

therapy-resistant pancreatic cancer stem cells through selective sensitization and radiation therapy.


61. Seible DM, Cardillo N, Fero KE, Murphy JD. The importance of local tumor control in pancreatic

cancer. Proceedings of the 57th Annual ASTRO Meeting, September 2016.

62. Williamson CW, Noticewala SS, Salinas CR, Murphy JD. Cost-effectiveness of proton therapy for

esophageal cancer. Proceedings of the 57th Annual ASTRO Meeting, September 2016.

63. Neppala P, Larson G, Panjwani N, Bryant AK, Sherer M, Murphy JD, Gillespie EF. Impact of an

interactive contouring module on knowledge and interest in radiation oncology among pre-clinical

medical students: a randomized trial. Proceedings of the 58th Annual ASTRO Meeting, September

2017. 99(2):E123.

James D Murphy

16

64. McClelland S, Kim E, Passias PG, Murphy JD, Attia A, Jaboin JJ. Spinal stereotactic body

radiotherapy in the United States: a decade-long nationwide analysis of patient demographics,

practice patterns, and trends over time. Proceedings of the 58th Annual ASTRO Meeting, September

2017. 99(2):E92-E3.

65. McClelland S, Kim E, Jaboin JJ, Murphy JD, Attia A. Treatment of spinal metastases in the United

States: comparison of conventional external beam radiation therapy versus stereotactic body radiation

therapy utilization over a multi-year timespan. Proceedings of the 58th Annual ASTRO Meeting,

September 2017. 99(2):E93.

66. Lim TY, Gillespie EF, Li N, Ziemer B, Sherer M, Murphy JD, Moore KL. Dosimetric impact of

contour variation in head-and-neck anatomy. Proceedings of the 58th Annual ASTRO Meeting,

September 2017. 99(2):E353.

67. Kim E, Westover KD, Daly ME, Murphy JD, Mitin T. Use of hypofractionated radiation therapy

with Concurrent Chemotherapy in Inoperable Stage II/III Non–small Cell Lung Cancer.

International Journal of Radiation Oncology • Biology • Physics. Proceedings of the 58th Annual

ASTRO Meeting, September 2017. 99(2):E468.

68. Kim E, Daly ME, Westover KD, Murphy JD, Mitin T. Modern Non-operative Treatment Strategies

for patients with stage II-III non-small cell lung cancer in the United States. Proceedings of the 58th

Annual ASTRO Meeting, September 2017. 99(2):E468-9.

69. Kaderka R, Gillespie EF, Mundt R, Bryant AK, Cornell M, Atwood T, Murphy JD. Potential pitfalls

when using surrogate radiation dose measures in place of real dosimetric data in radiation

epidemiology research. Proceedings of the 58th Annual ASTRO Meeting, September 2017.

99(2):S217.

70. Huynh-Le MP, Bryant AK, Simpson DR, Murphy JD. HIV status and anal cancer treatment

outcomes. Proceedings of the 58th Annual ASTRO Meeting, September 2017. 99(2):E156.

71. Gensheimer MF, Hong JC, Chang-Halpenny CN, Eclov N, To J, Murphy JD, Wakelee HA, Neal

JW, Le QT, Hara W, Quon A, Maxim PG, Graves EE, Olson MR, Diehn M, Loo BW, Jr. Mid-

radiation therapy PET/CT for prognostication and detection of early progression in patients with stage

III non-small cell lung cancer. Proceedings of the 58th Annual ASTRO Meeting, September 2017.

99(2):E456.

72. Bryant AK, Mundt R, Sandhu APS, Urbanic JJ, Sharabi A, Gupta S, Daly ME, Murphy JD.

Stereotactic body radiation therapy versus surgery for early non-small-cell lung cancer in the

Veterans Affairs System. Proceedings of the 58th Annual ASTRO Meeting, September 2017.

99(2):E442.

73. Bryant AK, Huynh-Le MP, Simpson DR, Sharabi A, Murphy JD. Impact of posttreatment CD4

count on tumor recurrence among HIV positive anal cancer patients. Proceedings of the 58th Annual

ASTRO Meeting, September 2017. 99(2):S65-6.

74. Bryant AK, Huynh-Le MP, Simpson DR, Murphy JD. Comparative effectiveness of IMRT and 3D

conformal radiation therapy for anal cancer. Proceedings of the 58th Annual ASTRO Meeting,

September 2017. 99(2):S67.

James D Murphy

17

INVITED PRESENTATIONS

1. Inhibition of mTOR radiosensitizes soft tissue sarcoma and tumor vasculature. Proceedings of the

49th Annual ASTRO Meeting, November 2007.

2. Duodenal toxicity in single-fraction stereotactic body radiotherapy. Proceedings of the 51st Annual

ASTRO Meeting, November 2009.

3. Post-radiation threshold tumor volume predicts outcome in head-and-neck cancer. American Radium

Society, 92nd

Annual Meeting, May 2010.

4. Correlation between metabolic tumor volume and pathologic tumor volume in head and neck cancer.

American Radium Society, 93rd

Annual Meeting, May 2011.

5. Inequality in palliative radiotherapy: a population-based analysis. Proceedings of the 53rd

Annual


6. UCLA Radiation Oncology Educational Symposium. GI case review presentation. University of

California Los Angeles, April 2015.

7. Summary of cost: end of life utilization for pain management. Radiotherapy utilization near end of

life educational session. Proceedings of the 57th Annual ASTRO Meeting, October 2015.

8. Outcomes Research in Oncology (Keynote Speaker). Winter Institute of Medical Physics, February

2016.

9. Who's afraid of the big bad oncologist? The role of the individual physician on patient health

outcomes (Visiting Faculty Scholar). Oregon Health & Science University, February 2016.

10. Who’s afraid of the big bad oncologist? The role of the individual physician on patient health

outcomes. Kaiser Center for Health Research, Portland OR. February 2016.


California Los Angeles, March 2016.

12. GI – Large data analysis – Discussant. Proceedings of the 58th Annual ASTRO Meeting, September

2016.

13. Dysfunctional healthcare delivery; the overlooked obstacle in the war on cancer. UC San Diego

Osher Institute, September 2016.


California Los Angeles, February 2017.

TEACHING

Stanford Palliative Care morning lecture series. “Radiotherapy from a palliative care perspective”. May

2010, September 2010, October 2011 (guest lecturer)

James D Murphy

18

Stanford CBIO242 - Scientific Basis of Clinical Cancer Therapy. “Economic impact of cancer therapy”.

May 2011, May 2012 (guest lecturer)

Stanford HRP262 - Intermediate biostatistics: regression, prediction, survival analysis. March-June 2011

(teaching assistant).

UC San Diego RMAS 410 – Radiation Oncology 3rd

year medical student selective (course director),

January 2014 – present.

UC San Diego RMAS 429 – Radiation Oncology 4th year medical student clerkship (course director).

January 2014 – present.

UC San Diego Medical School – 2nd

year Problem Based Learning – gastrointestinal, and oncology

sequences (group leader). October 2013 – present.

UC San Diego Medical School – 1st year Problem Based Learning – gastrointestinal sequence (group

leader). November 2013 – present.

UC San Diego Medical School – Practice of Medicine II Observed Structured Clinical Exam (examiner).

March 2014.

UC San Diego CLRE 264 – Clinical Decision Making (course director). I oversee the course which

consists of ten lectures (and computer labs) two hours each, homework, and a final for ~25 students.

Summer quarter 2015 – present.

UC San Diego CLRE 260 – Directed Studies in Clinical Research. January-March 2016 (students Anna

Schönbrunner, and Kelly Fero).

UC San Diego RMAS 296 – Independent Study. January-March 2016 (student Nick Cardillo).

UC San Diego CLRE 252 – Health Services Research (course director). I oversee this course which

involves ten lectures (and labs) two hours each, homework, and a final project for ~30 students. I teach

this course twice per year. 2016 – present.

GRADUATE STUDENT MENTORING

Peter Hawkins (2013): Independent Study Project (ISP) Chair (UC San Diego)

Daniel Triplett (2014-2015): Thesis advisor for MPH (San Diego State University)

Isabel Boero (2014-2015): Thesis advisor for MS in Clinical Research (UC San Diego)

Somia Said (2015-2016): Thesis advisor for MPH (San Diego State University)

Kelly Fero (2015-2016): Thesis advisor for MS in Clinical Research (UC San Diego)

Anna Schoenbrunner (2015-2016): Thesis advisor for MS in Clinical Research (UC San Diego)

Boryana Eastman (2015): Independent Study Project (ISP) Chair (UC San Diego)

Niloofar Latifi (2016): Independent Study Project (ISP) Chair (UC San Diego)

Joe Acevedo (2016): Thesis advisor for MS in Clinical Research (UC San Diego)

Marquis (Jue) Hou (2016-): Dissertation committee member for PhD in Mathematics (UC San Diego)

Alex Bryant (2016-2017): Thesis advisor for MS in Clinical Research (UC San Diego)

Abdullah Alsaggaf (2017): Thesis advisor for MS in Clinical Research (UC San Diego)

Ahmadreza Hatamipour (2017): Thesis advisor for MS in Clinical Research (UC San Diego)

Viridiana Tapia (2017): Thesis advisor for MS in Clinical Research (UC San Diego)

Arvin Wali (2017): Thesis advisor for MS in Clinical Research (UC San Diego)

James D Murphy

19

Jenna Borok (2017): Thesis committee member for MS in Clinical Research (UC San Diego)

Albenayan Rahaf (2017): Thesis committee member for MS in Clinical Research (UC San Diego)

Ziwei Wang (2017): Independent Study Project (ISP) Chair (UC San Diego)

Wendi Lebrett (2018): Independent Study Project (ISP) Chair (UC San Diego)

Michael Sherer (2018): Independent Study Project (ISP) Chair (UC San Diego)

Pushpa Neppala (2018): Independent Study Project (ISP) Chair (UC San Diego)

FUNDING

2011-2013 Varian Master Research Agreement ($10,000)

Palliative radiotherapy at the end-of-life; a SEER-Medicare analysis

Role: Principal Investigator

2012-2014 ASCO Young Investigator Award ($50,000)

Inequality, utilization and cost of palliative radiotherapy: a population-based study


2012-2015 UCSD Start-Up Grant ($100,000)

2013-2016 NIH/UCSD KL2 Award (NIH KL2 RR031978; $100,000/year x3 years)

Impact of provider and hospital experience in head-and-neck cancer


2013-2014 UCSD Academic Senate Seed Grant ($9,800) – declined.

Does experience with radiotherapy matter in gastrointestinal cancer?


2014-2015 UCSD Academic senate grant ($10,000)

Creation and implementation of a novel claims-based palliative prognostic tool


2014-2015 Patient-Centered Outcomes Research (PCOR) Trust Fund ($40,000)

Patterns of radiation therapy delivery among elderly women with breast cancer


2014-2016 National Comprehensive Cancer Network Young Investigator Award ($150,000)

Breast cancer radiation among elderly women in the US: assessing the impact of NCCN

guidelines on nationwide patterns of care.


2014-2017 ASTRO/ROI Comparative Effectiveness Research Award ($100,000)

Hypofractionated radiation for breast cancer across the US: a patterns of care and

comparative effectiveness study.


2014-2015 Varian Master Research Agreement ($80,000)

Novel 4D fiducial-less motion management strategy for liver and pancreas stereotactic

body radiotherapy.

Role: Co-Principal Investigator with Todd Atwood.

2016-2017 NIH U54 (NIH CA132379; $10,000 seed grant)

James D Murphy

20

Visualizing socioeconomic and racial disparities in the burden of screening detectable

cancers using GIS and web mapping tools

Role: Co-Investigator of seed grant

2016-2017 AHRQ R03HS024321 ($100,000)

Interactive contouring atlas for radiation oncology


2016- NIH UL1 (NIH UL1TR001442; 5% salary support)

UC San Diego Clinical and Translational Research Institute

Role: Health Services Research Education Module Director

2017-2018 NIH U54 (NIH CA132379; $49,569 pilot project)

Is it race, or place? Disentangling racial, socioeconomic and geographic disparities in

the cancer burden of San Diego and Imperial counties

Role: Co-Principal Investigator of pilot grant with Caroline Thompson

2017-2018 UCSD Head and Neck seed grant ($15,000)

Creating a Novel Simulation-Based Education Tool to Improve Radiation Therapy

Outcomes in Head & Neck Cancer


2017-2018 UCSD AIM Program grant ($20,000)

OncDoc – linking smart cancer patients to better cancer doctors


2017-2018 UCSD Academy of Clinician Scholars ($5,000)

Outreach Program to Inspire Minority and Underrepresented Students (OPTIMUS)


PROFESSIONAL MEMBERSHIP

2007- American Society for Therapeutic Radiation Oncology

2008- American College of Radiology

2008- American Society of Clinical Oncology

2008- The Radiological Society of North America

2008- Association of Residents in Radiation Oncology

EDITORIAL ACTIVITIES

International Journal of Radiation, Biology, Physics – Associate Senior Editor

Cancer Epidemiology, Biomarkers & Prevention – Ad Hoc Reviewer

Journal of Pain and Symptom Management – Ad Hoc Reviewer

Practical Radiation Oncology – Ad Hoc Reviewer

Diseases of the Esophagus – Ad Hoc Reviewer

Journal of the National Cancer Institute – Ad Hoc Reviewer

Journal of Clinical Oncology – Ad Hoc Reviewer

Cancer – Ad Hoc Reviewer

JAMA Oncology – Ad Hoc Reviewer

James D Murphy

21

OTHER WORK EXPERIENCE

2000-2001 US National Rowing Team Athlete

2001-2002 Princeton Review – Led review courses for pre-medical students preparing for the MCAT.

VOLUNTEER

1996-2000 Tutor – Taught undergraduates throughout four years of college.

2002-2003 MedBuddies – Volunteer buddy for patients in Mott Children’s Hospital.

2009-2012 Pacific Free Clinic – Primary care physician for underserved patients in Santa Clara

County.

2011-2012 Interviewer – Stanford Medical School Admissions Committee.

2013-2014 UCSD Doc-4-a-day volunteer – program for local minority high school students to

increase exposure to medicine.

PERSONAL

Hobbies include cycling, hiking, snowboarding, surfing, sailing, bartending, and medical statistics.

james murphy cv - uc san diego school of medicine · 2016 red journal outstanding reviewer award...

Documents